info@sannova.net +1 (732)560-0066

Are you looking for an efficient contract research service provider?

For your Bioanalytical, Preclinical, Phase I-IV, or CMC analytical needs in the area of small and large molecules, peptides, proteins, biomarkers, controlled substances and more

Our services

Bioanalytical

From small molecule bioanalysis to large molecules, in vitro studies, & more, Sannova continues to grow with the new areas of pharmaceutical science

Clinical

Sannova works with clinical organizations around the world to complete your studies in smooth coordination

CMC Analytical

With varied and specialized equipment, Sannova is able to handle a wide range of your CMC needs with the utmost focus on quality.

Our Clients

Sannova supports pharmaceutical, biotech, and clinical partners of all sizes across the globe

Client Feedback

At Sannova, we have a team of experts who aim to surpass the expectations of our clients.

Absolutely, I would be pleased to be a reference so that I can praise your unsurpassed flexibility, quality and turn-around to results. I’ll think about whether there is something better to say than unsurpassed and the best. If I come up with anything, I’ll add that as well.

Sr. Vice President

Regulatory Affairs, Clinical Development & Quality Assurance

I always speak good of you, your company and the efficiency which is exhibited in addition to the optimal costs.



Director

Research & Development

I wanted to let you know that we received FDA approval of our Argatroban NDA yesterday. On behalf of our company, I’d like to also thank you and the entire Sannova team for your efforts in supporting the studies under very tight timelines - we did not receive a single question on the clotting studies or the associated Sannova validation/testing during the review.

Chief Scientific Officer

We received confirmation from our Regulatory Affairs group that the file was received by the FDA. Many thanks to your entire team for their hard work and dedication on these studies! Your efforts have allowed us to submit on the same day that our stability data was available.

Executive Director

Research & Development